Y-Intercept (HK)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.79M | Buy |
141,668
+137,443
| +3,253% | +$7.56M | 0.19% | 115 |
|
|
2025
Q1 | $299K | Sell |
4,225
-486
| -10% | -$34.4K | 0.02% | 909 |
|
|
2024
Q4 | $310K | Sell |
4,711
-23,519
| -83% | -$1.55M | 0.02% | 926 |
|
|
2024
Q3 | $1.98M | Buy |
+28,230
| New | +$1.98M | 0.12% | 213 |
|
|
2023
Q3 | – | Sell |
-9,384
| Closed | -$813K | – | 1088 |
|
|
2023
Q2 | $813K | Buy |
+9,384
| New | +$813K | 0.09% | 373 |
|
|
2023
Q1 | – | Sell |
-14,769
| Closed | -$1.53M | – | 1189 |
|
|
2022
Q4 | $1.53M | Buy |
14,769
+10,213
| +224% | +$1.06M | 0.23% | 103 |
|
|
2022
Q3 | $386K | Buy |
+4,556
| New | +$386K | 0.04% | 628 |
|
|
2022
Q2 | – | Sell |
-6,487
| Closed | -$500K | – | 874 |
|
|
2022
Q1 | $500K | Buy |
6,487
+3,664
| +130% | +$282K | 0.11% | 264 |
|
|
2021
Q4 | $249K | Buy |
+2,823
| New | +$249K | 0.06% | 452 |
|
|
2021
Q3 | – | Sell |
-21,479
| Closed | -$1.79M | – | 656 |
|
|
2021
Q2 | $1.79M | Buy |
+21,479
| New | +$1.79M | 0.46% | 25 |
|
|
2021
Q1 | – | Sell |
-5,103
| Closed | -$444K | – | 630 |
|
|
2020
Q4 | $444K | Buy |
+5,103
| New | +$444K | 0.19% | 187 |
|